Apelin has long been known for its adipokine function, induced by insulin and modulating glucose and lipid metabolism as well as insulin sensitivity, which is why pharmacological targeting of the apelin receptor gained much interest for the treatment of type two diabetes (T2D) and metabolic diseases (Castan-Laurell et al., 2012). Here, INS is linked to Other metabolic disease.